Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-05-05T06:14:28.967Z Has data issue: false hasContentIssue false
  • English
  • Français

Erythromycin in the treatment of Otitis Media with Effusion(OME)

Published online by Cambridge University Press:  29 June 2007

S. Ernstson  and
L. Sundberg
S. Ernstson
Affiliation:
Karlskrona, Sweden
L. Sundberg*
Affiliation:
Karlskrona, Sweden
*
The ENT Department, Central Hospital, S-371 85 Karlskrona, Sweden
Get access Rights & Permissions [Opens in a new window]

Summary

Previous studies havd shown erythromycin to penetrate into both the middle-ear effusion and the adenoid tissue in children with Otitis Media with Effusion (OME). The levels obtained were similar to the plasma levels. Cultures in long-standing cases of OME have yielded respiratory pathogens—Haemophilus influenzae, streptococcus pneumoniae and Branhamella catarrhalis—in the nasopharynx in 79 per cent and in the middle-ear effusion in per cent.

In the present investigation a group of children with OME of more than three months' duration were given erythromycin (Abboticin®) in standard dosage for the last 10 days prior to scheduled operation (paracentesis or tympanostomy). Resolution was determined as normalization of the middle ear status, and this led to cancellation of surgery. The rate of resolution—12/26 (45 per cent)—was significantly higher than in a similar group of children not treated with erythromycin—11/72 (15 per cent). There are thus rational reasons for using erythromycin in OME, in many cases as an alternative to tympanostomy.

Type
Research Article
Information
The Journal of Laryngology & Otology , Volume 98 , Issue 8 , August 1984 , pp. 767 - 769
Copyright
Copyright © JLO (1984) Limited 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Healy, G. and Smith, H. (1981) Current concepts in the management of otitis media with effusion. American Journal of Otolaryngology, 2: 138–144.CrossRefGoogle ScholarPubMed
Kamme, C. (1971) The aetiology of acute otitis media in children and the relationship between bacterial characters and the clinical course in penicillin V therapy. Thesis. Staffanstorp Tryckeri AB, Sweden.Google Scholar
Lundgren, K. and Rundcrantz, H. (1976) Microbiology in serous otitis media. Annals of Otology, Rhinology and Laryngology, Supplement 25, 85: 152–155.CrossRefGoogle ScholarPubMed
Marks, N. J., Mills, R. P. and Shaheen, O. H. (1981) A controlled trial of co-trimoxazole therapy in serous otitis media. Journal of Laryngology and Otology, 95: 1003–1009.Google Scholar
Melén, I., Pipkorn, U., Rundcrantz, H. and Kamme, C. (1982) Elimination of bacteria from the nasopharynx. Acta Oto-Laryngologica (Stockholm), Supplement 386: 1003–1005.Google Scholar
Sundberg, L., Edén, T., Ernstson, S. and Pahlitzsch, R. (1979) Penetration of erythromycin through respiratory mucosa. A study using secretory otitis media as a model. Acta Oto-Laryngologica (Stockholm), Supplement 365: 1–17.Google ScholarPubMed
Sundberg, L., Edén, T. and Ernstson, S. (1981 a) Penetration of erythromycin in Waldeyer's ring—adenoid tissue. Acta Oto-Laryngologica (Stockholm), Supplement 384: 3–9.CrossRefGoogle ScholarPubMed
Sundberg, L, Cederberg, A., Edén, T. and Ernstson, S. (1981 b) Bacteriology in secretory otitis media. Acta Oto-Laryngologica (Stockholm), Supplement 384: 18–25.CrossRefGoogle ScholarPubMed
Sundberg, L., Cederberg, A., Edén, T. and Ernstson, S. (1983) The effect of erythromycin on the nasopharyngeal pathogens in children with secretory otitis media. Accepted for publication, Acta Oto-Laryngologica (Stockholm).Google Scholar
Virolainen, E., Suonpää, J. and Puhakka, H. (1982) Bacterial flora in the nasopharynx before and after the treatment of acute otitis media in children. Acta Oto-Laryngologica (Stockholm), Supplement 386: 97–99.CrossRefGoogle Scholar